Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Burkitt Lymphoma MeSH Descriptor Data 2025


MeSH Heading
Burkitt Lymphoma
Tree Number(s)
C01.925.256.466.313.165
C01.925.928.313.165
C04.557.386.480.150.165
C15.604.515.569.480.150.165
C20.683.515.761.480.150.165
Unique ID
D002051
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D002051
Scope Note
A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
Entry Term(s)
African Lymphoma
Burkitt Cell Leukemia
Burkitt Leukemia
Burkitt Tumor
Burkitt's Leukemia
Burkitt's Lymphoma
Burkitt's Tumor
Leukemia, Lymphoblastic, Burkitt-Type
Leukemia, Lymphocytic, L3
Lymphocytic Leukemia, L3
Lymphoma, Burkitt
Public MeSH Note
1998; see BURKITT'S LYMPHOMA 1968-1997; for LEUKEMIA, B-CELL, ACUTE & BURKITT LEUKEMIA see LEUKEMIA, B-CELL, ACUTE 1989-2007; for BURKITT TUMOR see BURKITT'S TUMOR 1968-1997; for LYMPHOMA, BURKITT see LYMPHOMA, BURKITT'S 1968-1997
History Note
1998 (1968)
Date Established
1968/01/01
Date of Entry
1999/01/01
Revision Date
2020/02/28
Burkitt Lymphoma Preferred
African Lymphoma Narrower
Burkitt Leukemia Related
page delivered in 0.125s